- Trials with a EudraCT protocol (133)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
133 result(s) found for: Saline injection.
Displaying page 2 of 7.
EudraCT Number: 2006-003509-18 | Sponsor Protocol Number: NAC0606 | Start Date*: 2007-08-13 |
Sponsor Name:University of Edinburgh [...] | ||
Full Title: Mechanisms for the effect of acetylcysteine on renal function after exposure to radiographic contrast material | ||
Medical condition: Radiocontrast-induced nephropathy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-000809-71 | Sponsor Protocol Number: APPI2-PT-2019-01 | Start Date*: 2019-06-18 | |||||||||||
Sponsor Name:The Parker Institute, Bispebjerg and Frederiksberg Hospital, The Capital Region of Denmark | |||||||||||||
Full Title: Direct comparison of intra-articular saline injections with an education plus exercise program for treatment of knee osteoarthritis symptoms: A randomised, open label, controlled, evidence based trial | |||||||||||||
Medical condition: Knee osteoarthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004159-19 | Sponsor Protocol Number: 2018-00938 | Start Date*: Information not available in EudraCT |
Sponsor Name:University Hospital Basel | ||
Full Title: Use of Copeptin Measurement after Arginine Infusion for the Diagnosis of Diabetes Insipidus - the CARGOx Study | ||
Medical condition: Polyuria-polydipsia syndrome (PPS) is divided into the three main entities central (complete or partial) diabetes insipidus (DI), nephrogenic DI and primary polydipsia (PP). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-004863-69 | Sponsor Protocol Number: 108494, 108516, 108518, 108520 | Start Date*: 2006-12-22 |
Sponsor Name:GlaxoSmithKline Biologicals | ||
Full Title: A phase II, single-blind, randomized, controlled, multicentre vaccination study to evaluate the safety and immune response of the GSK Biologicals Zoster vaccine, gE/AS01B, and to compare 3 doses of... | ||
Medical condition: Primary immunization of healthy elderly subjects (60 to 69 and more than or equal to 70 years) against zoster | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) SE (Completed) CZ (Completed) NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-004034-38 | Sponsor Protocol Number: MK-7684A-002 | Start Date*: 2021-04-19 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc | |||||||||||||
Full Title: A Phase 2, Multicenter, Randomized Study to Compare the Efficacy and Safety of MK-7684A or MK-7684A Plus Docetaxel Versus Docetaxel Monotherapy in the Treatment of Participants With Metastatic Non-... | |||||||||||||
Medical condition: Non Small Cell Lung cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Trial now transitioned) DK (Trial now transitioned) DE (Trial now transitioned) BE (Trial now transitioned) AT (Trial now transitioned) PL (Trial now transitioned) FR (Trial now transitioned) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000821-62 | Sponsor Protocol Number: ATR-2011 | Start Date*: 2011-09-19 |
Sponsor Name:Consorci Sanitari Terrassa | ||
Full Title: Comparación de la efectividad analgésica del bloqueo femoral, la infiltración intraarticular o la combinación de ambas en el control del dolor en la artroplastia total de rodilla. | ||
Medical condition: artroplastia total de rodilla | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-005757-12 | Sponsor Protocol Number: FAIR-HFpEF | Start Date*: 2017-06-06 |
Sponsor Name:Charité – Universitätsmedizin Berlin | ||
Full Title: Effect of IV iron (ferric carboxymaltose, Ferinject) on exercise tolerance, symptoms and quality of life in patients with heart failure with preserved ejection fraction (HFpEF) and iron deficiency ... | ||
Medical condition: Patients with heart failure with preserved ejection fraction (HFpEF) and iron deficiency (ID) with and without anaemia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2016-003939-38 | Sponsor Protocol Number: P160404J | Start Date*: 2017-12-19 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Short-term efficacy of a single ultrasound-guided intra-articular injection of botulinum toxin A associated with splinting for base-of-thumb osteoarthritis on pain at 3 months: A randomized placebo... | |||||||||||||
Medical condition: Patients referred to our Physical Medicine Rehabilitation Department of a tertiary care center in Paris, France, for the management of Base-of-thumb osteoarthritis (BTOA) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004188-11 | Sponsor Protocol Number: MK-3475-789 | Start Date*: 2018-05-09 | |||||||||||
Sponsor Name:Merck Sharp & Dohme LLC | |||||||||||||
Full Title: A Randomized, Double-Blind, Phase 3 Study of Pemetrexed + Platinum Chemotherapy with or without Pembrolizumab (MK-3475) in TKI-resistant EGFR-mutated Tumors in Metastatic Non-squamous Non-small Cel... | |||||||||||||
Medical condition: Metastatic Non-squamous Non-small Cell Lung Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) ES (Completed) FR (Completed) DE (Completed) GB (GB - no longer in EU/EEA) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005547-23 | Sponsor Protocol Number: 12217 | Start Date*: 2021-07-22 |
Sponsor Name:AZ Delta vzw | ||
Full Title: Management of Popeye sign with botulinum toxin after tenotomy of the long head of the biceps tendon: a double-blinded randomized controlled trial | ||
Medical condition: Popeye sign or cramping pain after shoulder artroscopy with biceps tenotomy | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004343-12 | Sponsor Protocol Number: ICARISTrialProtocol | Start Date*: 2015-10-07 |
Sponsor Name:Mater Research Institute University of Queensland | ||
Full Title: Impact on Caesarean Section Rates Following Injections of Sterile Water | ||
Medical condition: Back pain in labour and childbirth | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-003252-38 | Sponsor Protocol Number: Hx-Inflam-302 | Start Date*: 2006-09-01 | |||||||||||
Sponsor Name:Genmab A/S | |||||||||||||
Full Title: An open label clinical pilot study with local injection of human antibody (HuMax-Inflam) for the treatment of inflammatory psoriasis | |||||||||||||
Medical condition: inflammatory psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004565-33 | Sponsor Protocol Number: EASI | Start Date*: 2006-11-16 | |||||||||||
Sponsor Name:Chemische Fabrik Kreussler & Co.GmbH | |||||||||||||
Full Title: Efficacy and safety of Aethoxysklerol compared to Sodium Tetradecyl Sulfate and Isotonic Saline (placebo) for the treatment of reticular veins and spider veins including subgroup to investigate the... | |||||||||||||
Medical condition: Patients suffering from varicose veins (spider veins or reticular veins in the legs) should be treated with a sclerosing agent. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002319-41 | Sponsor Protocol Number: HULP-VIR-2014-01 | Start Date*: 2015-05-11 | |||||||||||
Sponsor Name:Ana Boto de los Bueis | |||||||||||||
Full Title: Clinical and virologic assesment of two therapeutic options: antiviral Ganciclovir 0.15% ophthalmic gel and physiologic saline solution 0.9% used in patients with acute adenoviral conjuntivitis. | |||||||||||||
Medical condition: Acute adenoviral conjunctivitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004485-28 | Sponsor Protocol Number: 38RC15.214 | Start Date*: 2016-01-18 | |||||||||||
Sponsor Name:Centre Hospitalier Universitaire de Grenoble | |||||||||||||
Full Title: | |||||||||||||
Medical condition: Patients should be operated for cardiac surgery with cardiac bypass and in sinus rhythm, and for which the fact of the existence of impaired left ventricular function or the heaviness of the surgic... | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-002717-41 | Sponsor Protocol Number: TRAPEZIUS | Start Date*: 2023-06-27 |
Sponsor Name:HOSPITAL CLINIC DE BARCELONA | ||
Full Title: EFFICACY AND SAFETY OF LOCAL TREATMENT OF TRAPEZIUS MYOFASCIAL SYNDROME IN PATIENTS WITH FIBROMYALGIA THROUGH ULTRASOUND-GUIDED INTERFASCIAL BLOCK OF THE TRAPEZIUS MUSCLE | ||
Medical condition: TRAPEZIUS MYOFASCIAL SYNDROME IN FIBROMYALGIA PATIENTS | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-006583-35 | Sponsor Protocol Number: 06/Q2601/33 | Start Date*: 2007-02-13 | |||||||||||
Sponsor Name:Shrewsbury & Telford Hospital NHS Trust | |||||||||||||
Full Title: A comparison of two diluents commonly used in epidural steroid injection for the treatment of low back pain and sciatica | |||||||||||||
Medical condition: Low back pain and sciatica | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-013620-22 | Sponsor Protocol Number: SOFISEP | Start Date*: 2009-10-07 |
Sponsor Name:AZIENDA SANITARIA LOCALE BI DI BIELLA | ||
Full Title: Multicenter randomized open clinical trial for `lock` efficacy assessment of totally implantable vascular access device with saline solution vs heparin | ||
Medical condition: Cancer patients with totally implantable vascular access device | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-001221-10 | Sponsor Protocol Number: 2602-637 | Start Date*: 2008-11-10 |
Sponsor Name:Rigshospitalet, University of Copenhagen | ||
Full Title: Postconditioning used for the limitation of infarct size in patients with ST-elevation myocardial infarction (POSTCON). | ||
Medical condition: Patients with ST-segment elevation myocardial infarction (STEMI) are routinely treated with primary PCI (pPCI) as a world wide standard. Glucagon like peptide (GLP1) is a genuine hormone created in... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002124-32 | Sponsor Protocol Number: CUSA-081-HEM-01 | Start Date*: 2020-01-02 |
Sponsor Name:Chiesi Farmaceutici S.p.A. | ||
Full Title: READY 1: A Phase 3, Randomized, Double-Blind, Active and Placebo-Controlled Study on the use of CUSA-081 for Dysfunctional Central Venous Access Devices (CVADs) | ||
Medical condition: Catheter Occlusion Thrombosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) BE (Completed) ES (Prematurely Ended) RO (Ongoing) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
